key: cord-0748652-zw0icpxf
authors: Hannah, Andrew; Lowe, Terry
title: The effect of the SARS-CoV-2 pandemic on suspected cancer referrals at a regional head and neck unit
date: 2021-11-19
journal: Advances in Oral and Maxillofacial Surgery
DOI: 10.1016/j.adoms.2021.100226
sha: 6ab18791b3b7246bae5f0939d4381a95e204f888
doc_id: 748652
cord_uid: zw0icpxf

The novel coronavirus SARS-CoV-2, initially identified in late 2019 as a small case cluster, has rapidly become a global pandemic. Government restrictions, closure of primary care services, interruption of cancer screening programmes, and fear of contracting the virus have demonstrably led to a reduction in referrals for suspected cancer and delays to treatment across the United Kingdom. A retrospective analysis was carried out on suspected cancer referrals to the maxillofacial service at Aberdeen Royal Infirmary during the 12 months from March 2020, and compared with the 12 months prior. Suspected cancer referrals reduced by 38.6% (p < 0.001) during this period, with a reduction in the percentage referred by General Dental Practitioners. Further analysis shows a proportionate reduction in squamous cell carcinoma diagnoses, with other diagnoses remaining stable. Time from referral to first appointment, biopsy, and treatment showed no change. Stage at diagnosis and treatment modality was also unaffected. Assuming no change to the incidence of head and neck malignancies, over a third of new malignancies may have been undiagnosed during the 12 months from March 2020. Evidence for the impact of the pandemic is likely to become apparent as services return to pre-pandemic levels and these patients begin to present.

The novel virus SARS-CoV-2 was first identified among a small case cluster in Wuhan city, 25

China, geographically associated with a local wet market. 1 The first confirmed case in the UK was reported at the end of January 2020, 6 and the first 35 confirmed case in Scotland at the beginning of March. 7 By the end of March 2020 the UK 36 was in its first lockdown, with a public health order to stay at home for all but essential 37 travel. 8, 9 Around the same time General Dental practices stopped all routine treatment, 10 38 and General Medical practices were encouraged to engage with patients remotely where 39 possible. 11 Two further national lockdowns would occur during the following 12 months, 40 with varying levels of restriction on daily activity in-between. At the time of writing the 41 pandemic is ongoing. 42

The impact on patient care and access to services was immediate. Routine cancer screening 44 programmes were effectively paused from March 2020 across the UK, 12 and the number of 45 urgent suspected cancer (USC) referrals dropped, with reports that urgent referrals in 46

England fell by 60% in April 2020 compared with the same month a year prior. 13 Diagnostic 47 investigations were also affected, with a reduction in the number of investigations carried 48 out along with an increase in waiting times. It is difficult to accurately estimate the impact 49 of these on cancer deaths. A study published in The Lancet Oncology looking at breast, 50 colorectal, oesophageal, and lung cancers estimated approximately 3500 additional deaths 51 within 5 years across these groups as a direct result of the pandemic. 14 52 53 Head and neck cancer has not escaped the impact of COVID-19, with reductions in referrals, 54 delays in diagnoses, and alterations to treatment all reported in the literature. 15, 16, 17, 18, 19 In 55 this paper we analyse the impact of the pandemic on head and neck cancer at a regional 56 maxillofacial unit in Scotland. The data shows a reduction in both overall referrals and those of suspected malignancies. 127 This is in line with reports from other referral centres in the UK and worldwide. Our centre 128 saw a reduction of 38.6% in referrals for suspected malignancy, which coincides with the 129 reduction in the number of patients with confirmed malignancy included in our analysis. that the overall reduction consisted mainly of SCC diagnoses. It is difficult to hypothesise 158 why this may be, but one possibility is that this reduction includes asymptomatic patients 159 who would have otherwise been identified by routine screening. Further, symptoms of 160 lymphoma are difficult to ignore, and a new neck lump or B symptoms may be more likely to 161 prompt engagement with primary care than an asymptomatic oral lesion. 162 163 Our data shows that, once referred, patient management was similar compared to the year 164 prior to the pandemic. For the patients included in our analysis the referral to first 165 appointment, referral to biopsy, and referral to treatment times were similar, or in some 166 cases better. At first glance this is reassuring, and likely reflects prioritisation of the cancer 167 service during this difficult period. We expect increased demand going forward as services 168 return to pre-pandemic levels and begin to identify patients who have not accessed care 169 during this period. Our data on TNM staging and treatment modality is also unchanged, 170 likely due to a lack of increase in referral to appointment time and prioritisation of the 171 cancer service.

The SARS-CoV-2 pandemic has presented unique challenges to both patients, clinicians, and 174 the health service as a whole. Head and neck cancer care has not been exempted, and this 175 paper adds to the body of evidence showing how it has affected regional services in the UK. 176

Overall referrals have decreased dramatically, including referrals for suspected malignancy, 177 and this is likely to have a measurable impact on patient outcomes moving forward. 178

Prospective data collection would be beneficial to determine the extent of any impact, and 179 it would be interesting to see this data on a national level. Effective service planning and 180 appropriate funding is essential to ensure provision of specialist services is maintained as 181 we begin to normalise following this profoundly challenging period. 182

A familial cluster of pneumonia associated with the 2019 198 novel coronavirus indicating person-to-person transmission: a study of a family 199 cluster. The Lancet

A pneumonia outbreak associated with a new 202 coronavirus of probable bat origin

The first 12 months of COVID-19: a timeline of 205 immunological insights

WHO Director-General's opening remarks at the media 208 briefing on COVID-19

general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-210 briefing-on-covid

Prime Minister's Office. Prime Minister's statement on coronavirus

UK Cabinet Office. Staying at home and away from others (social distancing)

Scottish Government. Chief Dental Officer Letter to Dental Practitioners

COVID-19: video consultations and homeworking

The impact of the COVID-19 pandemic on 234

The impact of COVID -19 on head and neck cancer 243 diagnosis and disease extent

UK Head and neck cancer surgical capacity during the 246 second wave of the COVID-19 pandemic: Have we learned the lessons? COVIDSurg 247 collaborative

Recommendations for head and neck 250 surgical oncology practice in a setting of acute severe resource constraint during the 251 COVID-19 pandemic: an international consensus. The Lancet Oncology

Delayed presentation of head and neck cancer 254 patients during COVID-19 pandemic

Diagnosis and treatment delay of head and 257 neck cancers during COVID-19 era in a tertiary care academic hospital: what should 258 21

J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f